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Editorial 
Surgery: art or science? 
Birth of organ transplantation 
TE Starzl 
The revolution in organ transplantation that occurred 
between 1950 and 1963 can be used to illustrate the 
way that surgery has influenced science, all the while 
preserving a niche as an art form. This modern era of 
transplantation immunology had begun several years 
earlier when Peter Brian Medawar, a 24-year-old zoo-
logist fresh from graduate studies at Oxford Univer-
sity, was assigned to the service of the British plastic 
surgeon Dr Thomas Gibson to determine if skin allo-
grafts could be used to treat casualties from the Battle 
of Britain. 
First in human studies [1] and then with simple and 
logical rabbit experiments [2], it was shown that re-
jection of the skin was an immunologic phenomenon 
analogous to the cell mediated delayed hypersensiti-
vity that confers immunity to diseases such as tuber-
culosis [3-5]. The principal evidence was that repeti-
tive grafts from the same donor were rejected more 
rapidly with each successive attempt [1,2]. The donor 
specific sensitisation caused by repetitive grafting 
confirmed previous clinical observations by the sur-
geon Emil Holman of Stanford University in skin 
grafted burn victims [6]. 
THE FRENCH "TRANSPLANTATION CLUB" 
The potential value oftransplantation procedures had 
attracted the early attention of French surgeons and, 
eventually, many of the grand figures of French sur-
gery, medicine, and science contributed to the new 
field. Clinical transplantation activity began in 
France within the first few years of the 20th century, 
when Jaboulay in Lyon [7] and others in France and 
Germany performed animal to human kidney trans-
plantation [8-10]. Although the Russian Yu Yu 
Voronoy of Kiev reported the first known attempt at 
human to human renal transplantation in 1936 [11], 
the clinical field was quiescent until 1951 when Rene 
Kiiss [12] and Charles Dubost [13] of Paris and Mar-
ceau Servelle of Strasbourg [14] carried out a series 
of cadaveric renal transplantations. A short time later, 
the urologist Louis Michon at the Necker Hospital 
(Paris) and a team of vascular surgeons reported the 
now commonplace transplantation of a kidney from 
a live volunteer donor [15]. 
Visitors flocked to France in the early 1950s to learn 
first hand from this experience, including John Mer-
rill from the Peter Bent Brigham Hospital, Boston, 
who, with the young French physician, Jean Hambur-
ger, founded the medical discipline of nephrology. As 
important as the early and subsequent contributions 
of Kiiss [16] and Hamburger [17] were to transplan-
tation, the scientific basis for this specialty in France 
went far deeper. The roots of histocompatibility re-
search were nourished in Paris by Jean Dausset (No-
bel Laureate, 1980) [18]. In addition, Georges Mathe, 
the father of bone marrow transplantation [19], was 
part of the French "transplantation club" of the 1950s 
and early 1960s. 
THE SURGEONS ROLE 
At a technical level 
The kidneys in the early French cases were removed 
from convict donors after their execution by guillo-
tine. The pelvic kidney transplant procedure original-
ly used by Kiiss and refined subsequently by the 
French surgeons has been used hundreds of thousands 
of times, including for the celebrated identical 
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(monozygotic) twin transplantations performed by 
Murray (N obellaureate, 1990) and his associates [20] 
in Boston. The skills necessary to transplant the kid-
ney (the only candidate organ until the 1960s) were 
applications of what became increasingly sophistica-
ted conventional operative procedures during and af-
ter World War II. 
The vascular surgical technology originated early 
in the century in the experimental laboratory of the 
Frenchman Alexis Carrel [21] (Nobel Laureate, 
1912) and had a pervasive effect on essentially all 
surgical specialties. Although Carrel suspected that 
transplanted organs were not pennanently accepted 
because of an immunologic barrier, the biologic spe-
cificity of the field of transplantation awaited the de-
finitive studies of Medawar and Gibson. 
Such experimental work in the laboratory has been 
critical to each major step in the evolution of organ 
transplantation. Progress in animal models has been 
transferred to the clinics, and conversely, problems 
encountered in the patients have been brought back 
to the laboratory for clarification, thus a flux has been 
continuous since the time of Carrel. It resulted in the 
development of operative techniques, the improve-
ment of immunosuppression, and clarification of pre-
viously enigmatic physiologic principles. The objec-
tive was to avoid human experimentation, rather than 
depend on it, when the time came to apply these po-
tentially life-saving procedures in the clinic. 
At a leadership level 
A co-product of these efforts was the concept of team 
construction in the laboratory. The more experience 
gained in the laboratory, the better the team will per-
fonn in the human operating room. The actual opera-
tions require separate donor and recipient teams, the 
activities of which must be closely knit. During the 
transplant operation, co-operation among surgeons, 
anaesthesiologists, nurses, and technicians is essen-
tial. From the very beginning, one of the objectives 
of laboratory work was to create harmony within the 
team, and amongst the physician specialists with 
whom the team would react. 
The core roles of the surgeons and the steps invol-
ved in transplant operations are identical to those of 
conventional clinical practice. Someone, most com-
monly but not necessarily a surgeon, inevitably will 
emerge from this experience as the team leader. 
Rigidity, impatience, selfishness, dishonesty, inhu-
manity, ignorance, and poor organizational skills are 
disqualifying characteristics. In addition to posses-
sing these graces, as well as professional competence, 
the leader must have those scientific instincts which 
allow advances. 
PROGRESS AND CULTURE 
The Journal of the American Academy of Arts and 
Sciences (called "Daedalus") is a quarterly publica-
tion in which topics of social importance and interest 
are examined in depth. The winter 1998 issue entitled 
"Science and Culture" contained two articles that ex-
plored the interface between science and art. One was 
written by Gerald Holton (Mallinckrodt Professor of 
Physics Emeritus at Harvard) [22], and the other by 
Lorraine Daston (Director, Max Planck Institute for 
the History of Science, Berlin) [23]. 
Both described how the influence of the imagina-
tion had long awakened fear among the rank and file 
of scientists and physicians. Why? Because it could 
make up a world of its own that was livelier, lovelier, 
or more logical that the real world; this power, which 
feeds art, could be an invitation to fraud. In a 1961 
issue of the New England Journal of Medicine, the 
"real world" of transplantation was described by F 
McFarland Burnet (Nobel Laureate, 1960) in sombre 
tenns " ... much thought has been given to ways by 
which tissues or organs not genetically and antigen i-
cally identical with the patient might be made to sur-
vive and function in the alien environment. On the 
whole the present outlook is highly unfavourable to 
success... [24]". 
Yet, there already was a place for legitimate 
dreams. Once it was established that rejection was an 
immune reaction, strategies had begun to evolve to 
weaken the recipient immune system. By 1950-51, 
total body irradiation [25] and adrenal cortical ste-
roids [26, 27] had been shown in the experimental 
laboratory to delay skin rejection. The immunosup-
pressive effect was either minor ifthe animals survi-
ved, or lethal to the recipient if the grafts were spared. 
Although there appeared to be no margin of safety, 
the surgeon Joseph Murray demonstrated for the first 
time at the Peter Bent Brigham Hospital in January 
1959 that human renal transplantation was feasible, 
following sublethal total body irradiation (TBI) of a 
fratemal twin recipient [28]. The success with TEl 
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could not be duplicated at the Boston centre, but five 
more examples of long survival (two with unrelated 
kidney donors) were reported from Paris during the 
next 3 years on the services of Rene Kiiss [29] and 
Jean Hamburger [30]. 
Three years later (April, 1962), it was shown that 
the same result could be accomplished pharmacolo-
gically, using chronic therapy with azathioprine [31]. 
This advance was preceded by extensive studies in 
dogs by the Englishman Sir Roy CaIne [32]. Although 
the clinical results with azathioprine alone were no 
better than with total body irradiation, the fog of pes-
simism surrounding clinical organ transplantation lif-
ted dramatically in 1962 when azathioprine was sys-
tematically combined with dose-manoeuvrable 
prednisone at the University of Colorado [33]. Rejec-
tion that developed despite azathioprine treatment 
could be reversed surprisingly easily with high doses 
of the prednisone. More importantly, the subsequent 
need for maintenance immunosuppression with both 
drugs frequently declined. 
The same characteristic cycle of immunologic con-
frontation and resolution was soon observed with the 
liver [34], ultimately with all other transplanted who-
le organs, and over the next 3 decades with each of 
the increasingly potent new baseline drugs substitu-
ted for azathioprine. Recognition, reversal, and the 
progressively easier control of rejection was the base 
upon which the new and increasingly practical mul-
tidisciplinary specialty of transplantation was cons-
tructed. Thirty years and a revolution in immunology 
elapsed before the meaning of the mysterious change 
in host/graft relationship that began in the first few 
weeks after transplantation was resolved. 
This was made possible by a study of the still-sur-
viving early Colorado kidney and liver recipients who 
by then were as long as 30 years post-transplantation 
[35, 36]. Donor leukocytes of bone marrow origin 
(including pluripotent stem cells), which are part of 
the structure of all organ grafts (the so-called "pas-
senger leukocytes"), had migrated from the trans-
planted organs and could still be found in small num-
bers in the recipient skin, heart, lymph nodes, blood, 
and elsewhere. It is only now becoming clear how 
changes in the organ and the host caused by the mi-
gration and persistence of these donor cells allow "al-
lograft acceptance" [37]. 
How could the activities so long ago of the persons 
named here from France, England and the United 
States have had such an impact on medicine and 
science, particularly in a modem era in which indivi-
duals are increasingly viewed as mere cogs in a mul-
tidisciplinary machine? By obliterating the artificial 
distinction between art and science perhaps they were 
able to exercise the imagination and creativity of the 
artist. Their expressions of individuality allowed 
them to see and create things far beyond the reach of 
the comfortable Philistines who criticized their ef-
forts at the time. 
In his book, "The Sleepwalkers", Arthur Krestler 
wrote: "". 'Progress' can by definition never go 
wrong; [Darwinian] evolution constantly does; and so 
does the evolution of ideas, including those of 'exact 
science'. New ideas are thrown up spontaneously like 
mutations; the vast majority of them are useless crank 
theories, the equivalent of biological freaks without 
survival-value" [38]. Viewed from the vantage point 
of 1998, the ideas of the French surgeons of a half 
century ago, and Carrel long before then, were any-
thing but freaks. They were part of the primordium 
for the birth of organ transplantation. 
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